TI
EDIT icon

Trexquant Investment’s Editas Medicine EDIT Stock Holding History

Trexquant Investment’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,446
Closed -$93.6K – 1621
2024
Q3 		$93.6K Sell
27,446
-445,269
-94% -$1.94M ﹤0.01% 1480
2024
Q2 		$2.21M Buy
472,715
+273,510
+137% +$1.54M 0.03% 709
2024
Q1 		$1.48M Sell
199,205
-42,549
-18% -$354K 0.03% 765
2023
Q4 		$2.45M Buy
241,754
+54,245
+29% +$476K 0.06% 487
2023
Q3 		$1.46M Buy
187,509
+107,776
+135% +$924K 0.04% 604
2023
Q2 		$656K Buy
79,733
+56,244
+239% +$490K 0.02% 897
2023
Q1 		$170K Buy
+23,489
New +$209K ﹤0.01% 1345
2022
Q4 		– Sell
-49,978
Closed -$612K – 1451
2022
Q3 		$612K Buy
+49,978
New +$779K 0.02% 731
2022
Q1 		– Sell
-17,634
Closed -$468K – 1444
2021
Q4 		$468K Buy
+17,634
New +$607K 0.03% 677
2021
Q2 		– Sell
-26,467
Closed -$1.11M – 1186
2021
Q1 		$1.11M Buy
+26,467
New +$1.51M 0.1% 252
2020
Q4 		– Sell
-9,394
Closed -$264K – 1128
2020
Q3 		$264K Buy
9,394
+1,401
+18% +$45.6K 0.02% 970
2020
Q2 		$236K Buy
+7,993
New +$209K 0.02% 985
2019
Q2 		– Sell
-15,242
Closed -$373K – 885
2019
Q1 		$373K Sell
15,242
-81,169
-84% -$1.84M 0.03% 674
2018
Q4 		$2.19M Buy
96,411
+81,311
+538% +$2.21M 0.14% 218
2018
Q3 		$480K Buy
+15,100
New +$488K 0.04% 550
2018
Q2 		– Sell
-48,265
Closed -$1.6M – 972
2018
Q1 		$1.6M Buy
+48,265
New +$1.72M 0.11% 295
2017
Q4 		– Sell
-19,556
Closed -$470K – 1089
2017
Q3 		$470K Buy
+19,556
New +$372K 0.12% 295
2017
Q2 		– Sell
-24,303
Closed -$542K – 872
2017
Q1 		$542K Buy
+24,303
New +$504K 0.07% 497

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Trexquant Investment's EDIT Position: Q4 2024 in Review

Trexquant Investment sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 27,446 shares — an estimated $93.6K sold.

Trexquant Investment first reported a position in EDIT in Q1 2017 and held it in 18 quarters. The position peaked at $2.45M in Q4 2023. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Trexquant Investment reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Trexquant Investment sold 27,446 Editas Medicine shares in Q4 2024, an estimated $93.6K.
  • Trexquant Investment first reported a position in Editas Medicine in Q1 2017 and held it in 18 quarters.
  • Trexquant Investment's Editas Medicine position peaked at $2.45M in Q4 2023.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Trexquant Investment's 13F filing for Q4 2024, filed 12 Feb 2025.